1,740,780 research outputs found
CC-1088 Celgene Corp
No full textCC-1088, a thalidomide analog inhibitor of phosphodiesterase 4, was being developed by Celgene for the potential treatment of inflammatory diseases and myelodysplastic syndromes, and had undergone clinical trials. By April 2005, however, the company was no longer developing CC-1088, with CC-10004 presumed to be the preferred compound
Santa Fe (ATSF) 1088
No full textA photograph print showing Santa Fe (ATSF) 1088, 2-6-2, (BLW) class 1050, on freight train, Stillwater, OK
1088, març 17. Testament sacramental
No full textDeclaració jurada del 17 de març de 1088, feta pels testimonis Senifred Bellido i Golfred, sacerdots, sobre l'última voluntat de Renard Guillem que va morir el dia 21 de febrer de 1088 a casa d'Hug Sendredi. Nomena hereva universal a la seva dona Sança després de fer diversos llegats a Santa Maria de l'Estany, a Sant Miquel del Fai i altre
1088 press
No full text1088press è un progetto editoriale che nasce dalla consapevolezza del ruolo istituzionale e sociale che l’Alma Mater Studiorum – Università di Bologna si è assunta, fin dalla sua storica fondazione risalente al 1088, nel panorama internazionale dell’alta formazione e della ricerca accademica
Going Beyond Counting First Authors in Author Co-citation Analysis
Get PDFThe present study examines one of the fundamental aspects of author co-citation analysis (ACA) - the way co-citation
counts are defined. Co-citation counting provides the data on which all subsequent statistical analyses and mappings
are based, and we compare ACA results based on two different types of co-citation counting - the traditional type that
only counts the first one among a cited work's authors on the one hand and a non-traditional type that takes into
account the first 5 authors of a cited work on the other hand. Results indicate that the picture produced through this non-traditional author co-citation counting contains more coherent author groups and is therefore considerably clearer. However, this picture represents fewer specialties in the research field being studied than that produced through the traditional first-author co-citation counting when the same number of top-ranked authors is selected and analyzed. Reasons for these effects are discussed
IMP-1088 inhibits VACV spread and virus yield.
No full text(A) Step-wise illustration of virus yield, spread and cytotoxicity assays. (B) Quantification of VACV yield in the presence of IMP-1088. HeLa cells were infected with VACV WR at increasing concentrations of IMP-1088. The cells were harvested 24 hpi, lysed by freeze-thaw and virus yield was determined by plaque assay. Dotted line indicates 50% virus yield. (C) Measuring viral spread in the presence of IMP-1088 based on GFP expression. Cells were infected with VACV WR-GFP in the presence of different concentrations of IMP-1088. The concentration of IMP-1088 required to reduce viral spread by 50% (EC50) was determined. (D) Cytotoxic effects of IMP-1088 determined by LDH assay. All experiments were performed twice with two replicates in each experiment. Values represent means +/- SEM.</p
1088. Miraculum S. Sebastiani
No full text1088. Miraculum S. Sebastiani. In: Molinier Auguste. Les Sources de l'histoire de France - Des origines aux guerres d'Italie (1494). II. Époque féodale, les Capétiens jusqu'en 1180. Paris : A. Picard et fils, 1902. p. 35
- …
